glutathione s transferase p1 S-transferase (GSTP1) regulatory elements. This scheme Figure 1 from Glutathione S-transferase

Histology and immunohistochemistry The tissue samples were decalcified in 10% EDTA, embedded in paraffin, and sectioned at a thickness of 5 m

OASIS trials: establishing effective doses Phase 2 OASIS 1 findings: Tested multiple dose levels: 0.3mg, 0.6mg, 1.2mg, 2.4mg, 4.5mg weekly Duration: 26 weeks Primary endpoint: Weight loss at each dose Dose-response results: 0.3mg weekly: ~4% body weight loss 0.6mg weekly: ~6% body weight loss 1.2mg weekly: ~8% body weight loss 2.4mg weekly: ~10% body weight loss 4.5mg weekly: ~12% body weight loss Key insight: Clear dose-response relationship

Many research compounds require precise dilution ratios and controlled reconstitution conditions

Gitlitz, B

Antiarrhythmic Drug Therapy for Atrial Fibrillation

Vukojevi J, et al